|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Tenapanor>> Market Analysis Reports |
Market Analysis Reports of Tenapanor |
|
Hyperphosphatemia - Pipeline Review, H1 2020 Hyperphosphatemia - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia - Pipeline Review, H1 2020, provides an overview of the Hyperphosphatemia (Nutritional Disorders) ... Global Irritable Bowel Syndrome (IBS) Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 ... (Strain) Bekinda (IBS-D) SYN-010 Tenapanor Market Segment by Applications, can be divided ... Constipation - Pipeline Review, H1 2018 Constipation - Pipeline Review, H1 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Constipation - Pipeline Review, H1 2018, provides an overview of the Constipation (Gastrointestinal) pipeline landscape. ... Constipation - Pipeline Review, H2 2019 Constipation - Pipeline Review, H2 2019 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Constipation - Pipeline Review, H2 2019, provides an overview of the Constipation (Gastrointestinal) pipeline landscape. ... Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018 Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2018, provides an overview ... Global Hyperphosphatemia Therapeutics Market Size Study & Forecast, by Drug Class (Sevelamer, Calcium-based Phosphate Binders, Lanthanum Carbonate, Iron-based Phosphate Binders, Non-Phosphate Binders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Analysis, 2023-2030 ... the bloodstream. Additionally, medications like tenapanor may be used to reduce phosphate absorption ... obtained approval for the use of Tenapanor as a hyperphosphatemia treatment in China. This regulatory ... Hyperphosphatemia - Pipeline Insight, 2021 ... Products FC818 (ferric citrate) VS 505 Tenapanor PT20 EOS789 DS-2330b JPH 101 ... Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Hyperphosphatemia In Chronic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In ... 2023-2028 Global and Regional Irritable Bowel Syndrome (IBS) Therapeutics Industry Status and Prospects Professional Market Research Report Standard Version ... (Strain) Bekinda (IBS-D) SYN-010 Tenapanor By Applications: Hospital Research Key Indicators ... Global Irritable Bowel Syndrome Treatment Market - 2025-2033 ... supporting the clinical benefits of IBSRELA (tenapanor), a first-in-class drug approved for ... Hyperkalemia Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 ... . Ardelyx is innovating with its drug Tenapanor, designed to treat hyperkalemia, while AstraZeneca ... |